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Nephronophthisis-related ciliopathies (NPHP-RC)
are degenerative recessive diseases that affect
kidney, retina, and brain. Genetic defects in NPHP
gene products that localize to cilia and centrosomes
defined them as "ciliopathies.’’ However, disease
mechanisms remain poorly understood. Here, we
identify by whole-exome resequencing, mutations
of MRE11, ZNF423, and CEP164 as causing NPHP-
RC. All three genes function within the DNA damage
response (DDR) pathway. We demonstrate that,
upon induced DNA damage, the NPHP-RC proteins
ZNF423, CEP164, and NPHP10 colocalize to nuclear
foci positive for TIP60, known to activate ATM at
sites of DNA damage. We show that knockdown of
CEP164 or ZNF423 causes sensitivity to DNA dam-
aging agents and that cep164 knockdown in zebra-
fish results in dysregulated DDR and an NPHP-RC
phenotype. Our findings link degenerative diseases
of the kidney and retina, disorders of increasing prev-
alence, to mechanisms of DDR.INTRODUCTION
Nephronophthisis (NPHP) is a recessive cystic kidney disease
that represents the most frequent genetic cause of end-stage
kidney disease in the first three decades of life. NPHP-related cil-
iopathies (NPHP-RC) are single-gene recessive disorders that
affect kidney, retina, brain, and liver by prenatal-onset dysplasia
or by organ degeneration and fibrosis in early adulthood. Identi-
fication of recessive mutations in more than ten different genes
(NPHP1-NPHP13) revealed that their gene products share local-
ization at the primary cilia-centrosomes complex and mitotic
spindle poles in a cell-cycle-dependent manner, characterizing
them as retinal-renal ‘‘ciliopathies’’ (Ansley et al., 2003; Hilde-
brandt et al., 2011). Multiple signaling pathways downstream
of cilia have been implicated in the disease mechanisms of
NPHP-RC, including Wnt signaling (Germino, 2005; Simons
et al., 2005) and Shh signaling (Huangfu and Anderson, 2005;
Huangfu et al., 2003). However, despite convergence of cilio-
pathy pathogenesis at cilia and centrosomes it remains largely
unknown what signaling pathways downstream of cilia and534 Cell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc.centrosome function operate in the disease mechanisms that
generate the NPHP-RC phenotypes.
Centrosomal proteins have been recently implicated in DNA
damage response (DDR). Both pericentrin (PCNT), a core cen-
trosomal protein (Doxsey et al., 1994), as well as CEP152,
encoding a centrosomal protein required for centriolar duplica-
tion (Blachon et al., 2008), are defective in Seckel syndrome,
an autosomal-recessive disorder characterized by dwarfism,
microcephaly, and mental retardation (Griffith et al., 2008; Kalay
et al., 2011; Rauch et al., 2008). PCNT- andCEP152mutant cells
are also defective in ATR-dependent DDR signaling, consistent
with the fact that the first mutation identified in Seckel syndrome
was in ataxia-telangiectasia mutated and RAD3-related (ATR),
a key phosphoinositide 3-kinase-related protein kinase involved
in DDR signaling (O’Driscoll et al., 2003), but the mechanism of
the signaling defect is not fully understood.
The known NPHP genes explain less than 50% of all cases
with NPHP-RC, and many of the single-gene causes of NPHP-
RC are still unknown (Otto et al., 2011). The finding that some
of the recently identified genetic causes of NPHP-RC are ex-
ceedingly rare (Attanasio et al., 2007) necessitates the ability to
identify novel single-gene causes of NPHP-RC in single affected
families. To achieve this goal, we developed a strategy that
combines homozygosity mapping (HM) with whole-exome rese-
quencing (WER) (Otto et al., 2010). Because this approach allows
identification of multiple different causes of NPHP-RC within
a short time frame, it has the potential of delineating pathogenic
pathways.
Using this approach, we identify here mutations in three
NPHP-RC genes,MRE11, ZNF423, andCEP164, which together
suggest involvement of a DDR signaling pathway in NPHP-RC
pathogenesis.
RESULTS
Whole-Exome Resequencing Accelerates Discovery of
NPHP-RC Genes
Identification of monogenic causes of ciliopathies is limited by
their rarity (Attanasio et al., 2007), necessitatingmethods to iden-
tify ciliopathy-causing genes in single families by using WER.
However, WER typically yields hundreds of variants from normal
reference sequence (Ng et al., 2009), whereas only a single-gene
mutation will represent the disease cause. To overcome this limi-
tation, we here combinedWERwith HM (Hildebrandt et al., 2009)
in sib pairs affected with NPHP-RC and performed functional
analysis of the identified genes (Otto et al., 2010).
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Figure 1. Identification of Recessive Mutations in MRE11, ZNF423, and CEP164 in NPHP-RC Using HM and WER
Data regarding HMandmutations are shown for family A3471withMRE11mutation (A and B), family F874with ZNF423mutation (C and D), and family KKESH001
with CEP164 mutation (E and F). (A, C, and E) Nonparametric lod scores (NPL) are plotted across the human genome in three families (A3471, F874, and
KKESH001) with NPHP-RC (see also Table 1). The x axis shows SNP positions on human chromosomes concatenated from p-ter (left) to q-ter (right). Genetic
distance is given in cM. Maximum NPL peaks (Hildebrandt et al., 2009) (red circles) indicate candidate regions of homozygosity by descent. The genesMRE11,
ZNF423, and CEP164 are positioned (arrow heads) within one of the maximumNPL peaks. (B, D, and F) Homozygous mutations detected in families with NPHP-
RC. Family number (underlined), mutation (arrowheads), and predicted translational changes (in parenthesis) are indicated (see also Table 1). Sequence traces
are shown for mutations above normal controls. (For additional mutations in other families see also Table 1 and Figure S2).HM yielded positional candidate regions of homozygosity by
descent (Hildebrandt et al., 2009) in families A3471 (two regions),
F874 (nine regions), and KKESH001-7 (14 regions) (Figure 1),
who had one or more features of NPHP-RC, including NPHP,retinal degeneration, liver fibrosis, or cerebellar degeneration/
hypoplasia (Table 1). We then performed WER in one affected
individual of each of the three NPHP-RC families (Ng et al.,
2009; Otto et al., 2010). Remarkably, each of three NPHP-RCCell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc. 535
Table 1. Mutations of MRE11, ZNF423 and CEP164 in families with NPHP-RC
Family Individuals
Ethnic
Origin
Nucleotide
Alterationa,b
(Hg19 Position)
Deduced
Protein
Change
Exon
(State)
Continuous Amino
Acid Sequence
Conservation
Parental
Consanguinity
Kidney
(Age at ESKF) Eye (Age at RD) Other (at Age)
MRE11
A3471 -21 and -22 Pakistani c.1897C>T
(Chr11: 94,170,372)
p.R633X 16 (hom) N/A Yes No renal failure Normal -21: -21: CVA (MRI), ataxia,
dysarthria, myoclonus;
-22: CVA (MRI), ataxia
ZNF423
F874 -21 and -22 Turkey c.2738C>T (Chr16:
49,670,325)
p.P913L 5 (hom) (D. rerio) Yes NPHP ND CVH Infantile NPHP
Situs inversus
A106 -21 and -22 Iceland c.1518delC (Chr16:
49,671,545)
p.P506fsX43 5 (het) (X. tropicalis) No PKD LCA CVH (Joubert)
A111 -21 ? c.3829C>T (Chr16:
49,525,212)
p.H1277Y 9 (het) (D. rerio) ? PKD RD CVH, NPHP, perinatal
breathing abnormality,
tongue tumor
CEP164
F319 -21 and -22 Turkey c.32A>C (Chr11:
117,209,334)
p.Q11P 3 (hom) (Ch. Reinhardtii) Yes NPHP, no Bx;
-21: (8 years);
-22: (8 years)
-21: RD (11yr,
not yet blind); -22:
no RP at 8 yrs
-21: obesity? no
LF; -22: obesity? LF?
F59 -21, -22, -23 USA
(Europe)
c.277C>T, (Chr11:
117,222,588)
c.1573C>T (Chr11:
117,252,580)
p.R93W,
p.Q525X
5 (het),
13 (het)
(Ch. Reinhardtii),
N/A
No NPHP, no Bx;
-21: (9 years);
-22: (8 years);
-23: normal
-21: RD (6 years);
-22: LCA (legally
blind at 5 months);
-23: (2 years)
-22: NY (birth),
mild AI; -23: seizuresc,
substantial DD, mild ID
NPH505 ND c.1726C>T (Chr11:
117,257,920)
p.R576X 15 (hom) N/A Yes NPHP, Bx (8 yr) RD and flat ERG
(not blind)
CVH, FD, bilateral PD,
bronchiectasis (1 mo),
abnormal LFT, obesity
KKESH001-7 Saudi c.4383A>G (Chr11:
117,282,884)
p.X1460W
extX57
33 (hom) N/A Yes normal (RD) LCA, flat
ERG (blind <2 yr)
N/A
AI, aortic insufficiency; Bx, Kidney biopsy; CVH, cerebeller vermis hypoplasia; DD, developmental delay; ERG, electroretinogram; ESKF, end-stage kidney failure; FD, facial dysmorphism; het,
heterozygous; hom, homozygous; ID, intellectual disability; LCA, Leber congenital amaurosis; LF, liver fibrosis; LFT, liver function tests; MRI, magnetic resonance imaging; N/A, not applicable;
ND, no data; NPHP, nephronophthisis; NPHP-RC, nephronophthisis-related ciliopathies; NY, nystagmus; PD, polydactyly; RD, retinal degeneration; SS, short stature.
aAll mutations were absent from >270 healthy control individuals and from the ESP Exome Variant Server data base, except theCEP164 variant p.R576X (allele frequency in European Americans
1/7,019).
bcDNA mutation numbering is based on human reference sequences NM_014956.4 forMRE11, NM_015069.2 for ZNF423, and NP_055771 for CEP164, where +1 corresponds to the A of ATG
start translation codon.
cSeizures were intractable, generalized and/or partial complex.
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genes consecutively identified by this approach, MRE11,
ZNF423, and CEP164, suggested a functional connection to
the DDR pathway (Figure 1; Table 1).
A Mutation ofMRE11 in Progressive Cerebellar
Degeneration Suggests Link to DDR
In family A3471, two siblings had cerebellar vermis hypoplasia
(CVH), a central feature of NPHP-RC (Table 1). Homozygosity
mapping yielded two candidate loci (Figure 1A). WER detected
a homozygous truncation mutation (p.R633X) of MRE11 (Fig-
ure 1B; Table 1) previously described for CVH in another Pakis-
tani family (Stewart et al., 1999), suggesting a founder effect for
this allele. MRE11 is an essential component of the ATM-Chk2
pathway of DDR (Figure S1 available online), where it recruits
ATM (ataxia telangiectasia-mutated) to sites of DNA double-
strand breaks (Figure S1A). Rediscovery of thisMRE11mutation
in family A3471 thus generated an unexpected link between
NPHP-RC phenotype and the ATM pathway of DDR signaling
(Figure S1A).
Patients with the NPHP-RC Joubert Syndrome Have
Defects in ZNF423
Another link of NPHP-RC to the ATM pathway of DDR signaling
emerged from HM and WER in two siblings (F874) with infantile
onset NPHP, CVH, and situs inversus (Table 1). SNP mapping
yielded nine candidate regions of homozygosity by descent (Fig-
ure 1C). We identified in both affected individuals a homozy-
gous missense mutation (p.P913L; conserved in vertebrates) of
ZNF423 (Figure 1D). In addition, when examining 96 additional
Joubert syndrome (JS) subjects, we detected two heterozy-
gous-only mutations of ZNF423: p.P506fsX43 in family A106
and p.H1277Y in individual A111-21 (Table 1). Mutations of the
mouse ortholog Zfp423 cause reduced proliferation and ab-
normal development of midline neural progenitors resulting in a
loss of the cerebellar vermis (Alcaraz et al., 2006; Cheng et al.,
2007) similar to that seen in JS patients with CVH.
ZNF423 encodes a protein with 30 zinc fingers (Figure 2A).
Mouse models display phenotypic variability that is subject
to modifier genes, environment, and stochastic effects (Alcaraz
et al., 2011; Alcaraz et al., 2006), consistent with the variable
presentations of NPHP-RC patients. The homozygous mutation
p.P913L, located between zinc fingers 21 and 22 (Figure 2A),
most likely exerts recessive loss-of-function, analogous to the
Zfp423 mouse models.
We next examined whether the heterozygous-only mutations
(Table 1) lead to loss of function via a dominant mechanism,
using a proliferation assay in P19 cells (Figures 2B–2D). Muta-
tions were engineered into a FLAG-tagged ZNF423 cDNA and
assayed by a S-phase index, defined as the proportion of trans-
fected cells that incorporate BrdU in 1 hr, 48 hr after transfection.
Simple loss-of-function alleles should not interfere with endoge-
nous Zfp423 activity in this assay. Indeed, overexpression of
either wild-type or the homozygous p.P913L allele had no effect
(Figure 2D). However, transfection with either the p.P506fsX43
frame-shifting allele, which removes the zinc fingers required
for SMAD (similar to mothers against decapentaplegic) and
EBF (early B cell factor) interactions, and the H1277Y substitu-
tion allele, which destroys the terminal zinc finger required forEBF interaction, reduced the mitotic index to little more than
half that of cells transfected with green fluorescent protein
(GFP) control vector or other alleles of ZNF423 (Figures 2B–
2D). A dominant mechanism is plausible for the two heterozy-
gous mutations, as each is predicted to interfere selectively
with a subset of interaction domains (Figure 2A). Neither subject
had siblings, and DNA from parents was not available to deter-
mine whether the mutations occurred de novo.
We detected five additional putative mutations in highly con-
served (including histidine knuckle) residues of ZNF423 among
JS families (Table S1). Although these mutations have not been
confirmed functionally, the high incidence of predicted delete-
rious mutations found in patients but absent from 270 healthy
control individuals, dbSNP, and 1000 Genomes Project data
further support identification of ZNF423 as a causal gene in
NPHP-RC and JS.
ZNF423/OAZ was recently shown to interact with the DNA
ds-damage sensor PARP1 (poly-ADP ribosyl polymerase 1) (Ku
et al., 2003), which recruits MRE11 and ATM to sites of DNA
damage (Figure S1A). This indirectly linked ZNF423 to the ATM
pathway of DNA damage signaling (Figure S1A). We therefore
tested whether ZNF423 mutations affect interaction between
ZNF423 and PARP1. Coimmunoprecipitation verified the associ-
ation of ZNF423 and PARP1 in reciprocal assays (Figure 2E).
More importantly, the truncating mutation P506fsX43, which
we detected in a JS patient (Table 1), abrogates this interaction
(Figure 2E), whereas H1277Y inhibits multimerization of ZNF423
(Figure 2E). In addition, depletion of ZNF423 mRNA caused
sensitivity to DNA damaging agents (see below).
Furthermore, we identified ZNF423 as a direct interaction
partner of CEP290/NPHP6, which ismutated in NPHP-RC (Sayer
et al., 2006; Valente et al., 2006). In a yeast two-hybrid screen
of human fetal brain library with a CEP290 (JAS2; amino acids
1917–2479) ‘‘bait’’ we found three in-frame ‘‘prey’’ sequences
corresponding toZNF423 (amino acids 178-406). This interaction
was confirmed (Figures 2F and 2G). CEP290/NPHP6 is known to
interact with the NPHP-RC protein NPHP5 (Scha¨fer et al., 2008)
and localizes to the ciliary transition zone (Sang et al., 2011).
Mutations of CEP164 Cause NPHP-RC
We obtained 14 candidate regions by HM in a Saudi family
(KKESH001) of first-cousin parents with a child who had LCA
(which can be allelic with NPHP-RC) with nystagmus, hyperopic
discs, vascular attenuation, diffuse retinal pigment epithelium
atrophy, and nonrecordable ERG (Table 1) (Figure 1E). Using
WER we detected a homozygous point mutation in CEP164
(centrosomal protein 164 kDa) that abolished the termination
codon, adding 57 amino acid residues to the open reading frame
(p.X1460WextX57) (Figure 1F, Table 1). Themutation was absent
from 96 Saudi healthy controls and from 224 North American
LCA patients who lack mutations in other known LCA genes.
We performed exon-PCR and Sanger sequencing of all 31
coding exons for one affected individual in each of 856 different
NPHP-RC families (see Extended Experimental Procedures). We
detected bothmutatedCEP164 alleles in each of three additional
families with NPHP-RC (Table 1; Figure S2). We thereby identi-
fied recessive mutations of CEP164 as an additional cause of
NPHP-RC. Because of the significant overlap of phenotypicCell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc. 537
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Figure 2. Two ZNF423 Mutations Have
Dominant Negative Characteristics, ZNF423
Mutation Abrogates Interaction with PARP1,
and ZNF423 Directly Interacts with the
NPHP-RC Protein CEP290/NPHP6
(A) Amino acid residues altered by NPHP-RC
mutations in ZNF423 are drawn in relation to func-
tional annotation of its 30 Zn-fingers.
(B–D) S-phase index assay (fraction of transfected
cells incorporating BrdU) for P19 cells transfected
with either wild-type or mutant ZNF423. (B)
Representative field of cells transfected with wild-
type ZNF423 shows high frequency of BrdU+
FLAG+ double-positive cells. (C) ZNF423–H1277Y
transfected cells exhibits fewer FLAG–positive cells
and a lower proportion that are double positive. (D)
S-phase index measured in duplicate transfections
for each of three DNA preparations per construct. A
GFP construct was used as a nonspecific control.
Constructs with P506fsX43 and H1277Ymutations
detected in NPHP-RC show significantly reduced
S-phase index (p < 105, ANOVA with post-hoc
Tukey honestly significant difference [HSD]).
(E) ZNF423 interacts with PARP1. P19 cells were
cotransfected with expression constructs for N
terminally FLAG-tagged human full-length ZNF423
and V5-tagged human full length PARP1. Com-
parable amounts of both proteinswere present in all
lysates (lower panels). Proteins were precipitated,
using anti-V5 (upper panels) and anti-FLAG anti-
bodies (middle panels), respectively. Reciprocal
coIP demonstrates interaction between ZNF423
and PARP1. Note that the ZFN423 mutation
P506fsX43 abrogates this interaction (arrowhead)
and that mutation H1277Y diminishes ZNF423
multimerization (arrow).
(F–G) ZNF423 directly interacts with CEP290/
NPHP6. (F) A human fetal brain yeast two-hybrid
library screened with human CEP290/NPHP6
(JAS2; aa 1917–2479) fused to the DNA-binding
domain of GAL4 (pDEST32) identified ZNF423
as a direct interaction partner of CEP290/NPHP6.
The interaction was confirmed using direct yeast
two-hybrid assay where 1 and 2 represent colony
growth of CEP290 bait with ZNF423 prey. a–e are
controls for colony growth on medium deficient
in histidine, leucine and tryptophan. (G) HEK293T
were cotransfected with human V5-tagged partial
human V5-CEP290 clone and GFP-tagged full-
length human ZNF423 clone. Immunoprecipitation
with anti-V5 (lane 2), but not control IgG (lane 3)
precipitated both the V5-tagged CEP290 (arrow-
head) as well as GFP-tagged ZNF423 (arrow).features with other forms of NPHP-RC we introduce the alias
‘‘NPHP14’’ for ZNF423 and ‘‘NPHP15’’ for the CEP164 protein.
Although the number of families with CEP164 mutation is
small, our findings support a gradient of genotype-phenotype
correlations characteristic of NPHP-RC (Table 1), in which null
mutations cause the severe dysplastic phenotypes of Meckel
syndrome and JS, whereas hypomorphic alleles cause the
milder degenerative phenotypes of NPHP and SLSN (Hilde-
brandt et al., 2011). CEP164 is transcribed into three common
isoforms (Figures S2A–S2C) and is part of the photoreceptor
sensory cilium proteome (Liu et al., 2007). To study subcellular538 Cell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc.localization of the CEP164 protein, we utilized antibodies against
human CEP164 for immunoblotting and immunofluorescence
(Figure S3).
Mutation of CEP164 Interferes with Ciliogenesis
By confocal microscopy of GFP-labeled CEP164 protein with
other labels, we show that CEP164 colocalizes in hTERT-
RPE cells with the mother centriole, with the mitotic spindle
poles, and with the abscission structure in a cell-cycle-depen-
dent way (Figure S4), a feature characteristic of proteins in-
volved in single-gene ciliopathies (Otto et al., 2010; Graser
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Figure 3. Expression of Mutant CEP164 in
Renal Epithelial Cells Abrogates Localiza-
tion to Centrosomes
(A) Immunofluorescence using a-SDCCAG8/
NPHP10-CG antibody in MDCK cells, labels
both centrioles, whereas a-CEP164-ENR antibody
demonstrates CEP164 staining at the mother
centriole only.
(B) Inducible overexpression of N terminally
GFP-tagged human full-length CEP164 isoform
1 (NGFP-CEP164-WT) in IMCD3 cells demon-
strates, in addition to a cytoplasmic expression
pattern, localization at one of the two centrioles
(inset, arrow heads) consistent with selective
localization to the mother centriole (Graser et al.,
2007). Both centrioles are stained with an anti-g-
tubulin antibody.
(C) In contrast, the centrosomal signal is abro-
gated upon overexpression of an N terminally
GFP-tagged truncated CEP164 construct repre-
senting the mutation p.Q525X.
(D) The number of centrosomes positive for
CEP164 is reduced upon overexpression of C
terminally GFP-tagged human full-length CEP164
isoform 1 (CGFP-hCEP164-WT), which mimics
the mutation p.X1460WextX57 that causes a read-
through of the stop-codon X1460, adding 57
aberrant amino acid residues to the C terminus of
CEP164. Similar data were obtained upon CEP164
expression in hTERT-RPE cells (see also Figures
S3B–S3D). IMCD3 cells were stably transfected
with the respective CEP164 constructs in a retro-
viral vector for doxycyclin-inducible expression
(pRetroX-Tight-Pur). Scale bars, 10 mm.
(E–H) Knockdown of Cep164 disrupts ciliary
frequency. (E) Depletion of Cep164 by siRNA (F)
causes a ciliary defect in 3D spheroid growth
assays. IMCD3 cells transfected with either siCtrl or
siCep164 were grown to spheroids in 72 hr and
immunostained for acetylated tubulin (red). DAPI
stains nuclei (blue). Doxycycline induced stably
transfectedNGFP-hCEP164-WT (green). Spacebar
represents 5 mm. (G) Nuclei and cilia were scored
within a single spheroid to generate ciliary frequen-
cies. siCep164 transfected cells manifest lower cilia
frequencies (33%) compared to control transfected
IMCD3 cells (49%). Induction of NGFP-hCEP164-
WT in siCep164 transfected cells rescues this ciliary
defect (57%). 50 spheroids per condition were
analyzed in three independent experiments. Error
bars represent SEM, n = 3, *p value < 0.0002. (H)
Ciliary frequency is not rescued bymutant CEP164.
Ciliary frequencies are reduced in siCep164 transfected IMCD3 cells (39%) compared to control siCtrl transfected IMCD3 cells (54%). Induction of NGFP-hCEP164-
Q525X does not rescue this ciliary defect (34%). 50 spheroids per condition were analyzed. Error bars represent SEM, ***p value < 0.0002.
See also Figure S3.et al., 2007) and that this colocalization is abrogated by
mutations (Figure 3, Figures S3C–S3F). We thus demonstrated
lack of centrosomal localization for the truncating mutation
p.Q525X and for an equivalent of the p.X1460WextX57
mutation.
Loss of function of several genes that cause nephronophthisis
in NPHP-RC cause disruption of 3D architecture of renal epithe-
lial cell culture (Otto et al., 2010; Sang et al., 2011). To evaluate
CEP164 by this criterion, we transfected murine kidney IMCD3cells with siRNA oligonucleotides against murine Cep164, or
random sequences (Ctrl) in 3D spheroid growth assays. Cells
transfected with siCep164 developed spheroids with overall
normal architecture and size, but with markedly reduced
frequency of cilia (Figures 3E–3H). We conclude that Cep164
affects ciliogenesis or maintenance but that the overall architec-
ture of renal 3D growths is not as grossly affected as we have
previously seen for knockdown of other NPHP-RC genes
(Sang et al., 2011).Cell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc. 539
NPHP-RC Proteins Colocalize with the DDR Protein
TIP60 to Nuclear Foci
A noncentrosomal localization for CEP164 was described by
demonstrating its translocation to nuclear foci in response to
DNA damage (Pan and Lee, 2009; Sivasubramaniam et al.,
2008). CEP164 plays a role in DDR signaling where it interacts
with the DDR protein ATRIP (Figure S2C), is activated by the
DDR proteins ATM and ATR, and is necessary for checkpoint-
1 (Chk1) activation. Abrogation of CEP164 function leads to
loss of G2/M cell-cycle checkpoint and aberrant nuclear divi-
sions (Sivasubramaniam et al., 2008).
Localization of SDCCAG8 (alias NPHP10) (Otto et al., 2010),
shows nuclear foci in hTERT-RPE cells in addition to its centro-
somal localization (Figures 4B–4C). Transient shRNA knock-
down confirmed specificity of the signal (Figures S4B–S4D).
SDCCAG8/NPHP10 did not colocalize with markers for PLM
bodies (Janderova´-Rossmeislova´ et al., 2007) or CENP-C
(marking chromosomal centromeres) (Figures S5A and S5B). In
contrast, SDCCAG8/NPHP10 fully colocalized with SC35 in
hTERT-RPE cells (Figures 4A–4C). SC35, also known as
serine/arginine-rich splicing factor 2 (SRSF2), plays a role in
DDR by controlling cell fate decisions in response to DNA
damaging agents (Edmond et al., 2011; Reinhardt et al., 2011).
SC35 marks hubs of enhanced gene expression (Szczerbal
and Bridger, 2010), is phosphorylated by topoisomerase I (Elias
et al., 2003), and is required for genomic stability duringmamma-
lian organogenesis (Xiao et al., 2007). Moreover, ZNF423 also
fully colocalizes (Figure 4D), and CEP164 partially colocalizes
(Figure 4E) with SC35 in nuclear foci. Consequently, ZNF423
and CEP164 also colocalize with SDCCAG8/NPHP10 in SC35-
positive nuclear foci (Figures 4F and 4G).
SC35 functions within a TIP60 complex, in which TIP60 acety-
lates SC35 on lysine 52 (Figure S1B), modifying the role of SC35
in the promotion of apoptosis and inhibition of G2/M arrest (Ed-
mond et al., 2011), which is regulated by the checkpoint proteins
Chk1 and Chk2 (Figure S1D). Interestingly, the TIP60 protein, to-
gether with the heterotrimeric MRN complex (of which MRE11
is a component) constitutes the major activator of ATM within
the ATM pathway of DDR signaling (Ciccia and Elledge, 2010)
(Figure S1A). In hTERT-RPE cells the ATM activator TIP60 coloc-
alizes to nuclear foci with SC35/SRSF2 (Figure 4H) and partially
with the identified NPHP-RC protein CEP164 (Figure 4I). We
thus identify a group of NPHP-RC proteins and demonstrate
that they colocalize to nuclear foci with the DDR proteins TIP60
and SC35. These gene products include the identified NPHP-
RC proteins ZNF423 and CEP164 as well as SDCCAG8/
NPHP10. Interestingly, the protein OFD1, which is mutated in
the ciliopathy oral-facial-digital syndrome, is part of the TIP60
complex. We recently identified OFD1 as a direct interaction
partner of SDCCAG8/NPHP10 (Figure S1B) (Otto et al., 2010).
Cep164 Associates with DDR Proteins and Its Loss
Causes DDR Defects
Because one of the central mechanisms controlled by DDR
signaling is cell-cycle regulation through phosphorylation of
checkpoint-1 (Chk1) and checkpoint-2 (Chk2) proteins (Fig-
ure S1D), we tested whether Chk proteins are recruited to
SC35/SRSF2-positive nuclear foci. SC35 and p317-Chk1 coloc-540 Cell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc.alize to nuclear foci in hTERT-RPE cells (Figure 4J). We then
tested whether localization of CEP164 to nuclear foci was induc-
ible by DNA damage. Following irradiation with 20–50 J/m2 of
UV light, CEP164-positive nuclear foci condensed to larger
size and colocalized with TIP60 and Chk1 to foci of similar size
(Figures 4K–4O). TIP60 and p317-Chk1 colocalized within these
foci (Figure 4P). We thus demonstrate that CEP164 translocates
in response to DNA damage to nuclear foci that contain the DDR
proteins TIP60 and Chk1.
Lagging chromosomes on anaphase spindles (‘‘anaphase
lag’’) are a hallmark of many mutations that affect mitotic check-
point integrity. We show that siCep164 knockdown in IMCD3
cells increased anaphase lag from 1% in siCtrl controls to 21%
in siCep164-treated cells (Figures 5A and 5B, p = 0.04). This
phenomenon was specific, since doxycycline-inducible expres-
sion of WT-CEP164 during Cep164 siRNA knockdown reduced
the incidence of anaphase lag to just 4% (Figure 5B). These
data indicate a requirement for Cep164 at the G2/M checkpoint.
The DDR pathway can be activated by the CDK inhibitor
roscovitine, which also reduces Chk1 expression (Maude and
Enders, 2005). Roscovitine reduces the development of kidney
cysts in the Nphp9 mouse model, Jck (Bukanov et al., 2006).
We therefore tested the influence of roscovitine (targeting
CDK2, 5, 7 and 9) on DDR activation in IMCD3 cells. Immunoflu-
orescence shows increased uniform distribution of gH2AX (acti-
vated H2AX phosphorylated at Ser139) in the nucleus of IMCD3
cells upon roscovitine treatment in irradiated cells, indicating
partial DDR activation (Figure 5C). Second, in cells treated with
roscovitine, UV irradiation caused enhanced gH2AX staining
with a prominent nuclear foci pattern, characteristic of strong
DDR activation (Figure 5D). Immunoblotting showed that rosco-
vitine decreased the amount of CEP164 present in both control
and UV-irradiated cells (Figures 5E and 5F). This was most likely
due to translocation of CEP164 into the nucleus upon roscovitine
treatment, as shown by subcellular fractionation (Figure 5F). As
expected, UV radiation increased phosphorylation of Chk1 at
Ser317 (p-Chk1) (Figure 5E), and roscovitine decreased Chk1
protein expression and abrogated UV-induced p-Chk1 in both
cytoplasm and nucleus (Figures 5G and 5H). These data indicate
that CDK inhibition by roscovitine causes nuclear translocation
of CEP164 and inhibits Chk1 activation. gH2AX activation by
roscovitine may restore cell-cycle control by Chk2 activation
instead (Maude and Enders, 2005).
Human Wild-Type CEP164 but Not Its NPHP-RC
Truncation Mutant Rescues IMCD3 Cell Proliferation
In clonally selected IMCD3 cells expressing wild-type human
CEP164 cDNA construct N-GFP-CEP164-WT under doxycy-
cline (Dox) control, depletion of endogenous mouse Cep164
retarded proliferation in comparison to either undepleted control
cells or undepleted cells that were Dox-induced to overexpress
N-GFP-CEP164-WT alone (Figure 5G). Cep164-depleted growth
was rescued by Dox-induced expression of human N-GFP-
CEP164-WT (Figure 5G). Cells expressing truncated cDNA
construct N-GFP-CEP164-Q525X, modeling the NPHP-RC mu-
tation in family F59, exhibited retarded growth, even when the
endogenous Cep164 was present (Figure 5H), consistent with
a dominant negative effect. Further depletion of the endogenous
Figure 4. Colocalization upon Immunofluorescence of the NPHP-RC Proteins SDCCAG8/NPHP10, ZNF423 and CEP164 to Nuclear Foci that
Are Positive for the DDR Signaling Proteins SC35, TIP60 and Chk1 in hTERT-RPE Cells
(A–G) Colocalization of NPHP-RC proteins with SC35 in nuclear foci. SDCCAG8/NPHP10 (A-C) and ZNF423 (D) fully colocalize to nuclear foci with SC35, and (E)
CEP164 partially colocalizes with SC35. SDCCAG8/ NPHP10 also colocalizes with the identified NPHP-RC proteins ZNF423 (F) and CEP164 (G).
(H–J) Colocalization of NPHP-RCproteins with the DDRprotein TIP60 andChk1 to nuclear foci. (H) TIP60 fully colocalizes with SC35. (I) TIP60 partially colocalizes
with CEP164. (J) Chk1 fully colocalizes with SC35/ SRSF2. DNA is stained in blue with DAPI. Scale bars, 5 mm.
(K–P) Colocalization of DDR andNPHP proteins upon induction of DDR byUV radiation in HeLa cells. (K) Following irradiation of HeLa cells with UV light at 20 J/m2
a strong immunofluorescence signal of an anti-gH2AX antibody indicates activation of DDR. (L–M) Upon irradiation with UV light, CEP164-positive nuclear foci
condense and colocalize with TIP60 foci of similar size. (N–O) In untreated cells (N) a pattern of broad CEP164 speckles, which are Chk1-negative and locate to
DAPI-negative domains, changes to a pattern of multiple smaller foci (O) that are double positive for both CEP164-N11 and Chk1. (P) p317-Chk1 fully colocalizes
with TIP60 to nuclear foci and to the centrosome (arrowhead).
See also Figures S4, S5A, and S5B.
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Figure 5. Knockdown of Cep164 Causes Anaphase Lag and Retarded Cell Growth
(A and B) Knockdown ofCEP164 causes anaphase lag. siCep164 knockdown in IMCD3 cells increased anaphase lag incidence from 1% after siCtrl to 21% after
siCep164-treated cells (n > 250 anaphases, five independent experiments). CREST antiserum (red) and DAPI (blue) confirmed the presence of incomplete mitotic
congression and unattached kinetochores during late anaphase (white arrows). Doxycycline-inducible expression of WT-CEP164 during Cep164 siRNA
knockdown reduced the incidence of anaphase lag to 4%, whereas untransfected IMCD3 cells had no detectable anaphase lag (0%) (B). Bars represent SEM, p
values (Student’s t test) are indicated above the bar graph.
(C–F) The effect of roscovitine on UV-induced DDR. Cells were UV irradiated with 30 J/m2 and analyzed 1 hr after UV irradiation. Where indicated, cells were
preincubated for 24 hr with the CDK inhibitor roscovitine (80 mM). (C and D) Immunofluorescence analysis showed that roscovitine triggered uniform nuclear
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Cep164 in N-GFP-CEP164-Q525X-expressing cells showed an
additive effect on growth retardation, confirming the dominant
negative effect of N-GFP-CEP164-Q525X in this experimental
system (Figure 5H).
CEP164 Directly Interacts with CCDC92 and TTBK2
NPHP-RC proteins are known to interact with other NPHP-RC
proteins in the dynamic ‘‘NPHP-JS-MKS interaction network’’
(Sang et al., 2011).To identify novel direct interaction partners
of CEP164, we performed yeast two-hybrid screening. We iden-
tified CCDC92 and TTBK2 as direct interactors of CEP164
(Figures S5C–S5J). Interactions between CEP164 and both part-
ners were validated by GST pull-down (Figure S5D) and coim-
munoprecipitation (Figures S5E–S5H). Immunofluorescence
showed that CCDC92 fully colocalizes with CEP164 at the
mother centriole (Figures S5I and S5J).
CEP164 also interacted with NPHP3 and weakly with NPHP4
(Figures S6A–S6B), demonstrating that CEP164 is in a complex
with other known NPHP-RC proteins (Figures S1A and S1B). The
DDR protein DDB1 interacted with NPHP2 (Figures S6C and
S6D). The disheveled protein (Dvl), which is a central component
of the Wnt pathway, interacts with NPHP2/inversin targeting
Dvl for proteasomal degradation, thereby triggering a switch
from canonical to noncanonical Wnt signaling (Germino, 2005;
Simons et al., 2005). We identify interaction between Dvl3 and
CEP164 (Figures S6E–S6H). Immunocytochemistry reveals that
endogenous Dvl3 and CEP164 share centrosomal localization
(Figure S6E). We demonstrate that GST-CEP164 (aa 2–195) is
sufficient to pull down endogenous Dvl3 from the cellular lysate
(Figure S6F). Domain mapping for Dvl3 suggests that CEP164
interacts with the proline-rich region of Dvl3, because only
mutants containing this sequence efficiently coimmunoprecipi-
tate with CEP164-GFP (Figure S6G). Interestingly, only wild-
type CEP164-mCherryRFP but not the NPHP-RC causing
mutant CEP164-Q525X detected in family F59 (Table 1) can be
efficiently immunoprecipitated with Dvl3 (Figure S6H), further
supporting its pathogenic role.
cep164 Loss of Function Causes NPHP-RC and DDR
Activation in Zebrafish
To test in a vertebrate model whether loss of cep164 function
results in both, an NPHP-RC phenotype as well as DDR activa-
tion, we performed cep164 knockdown in zebrafish embryos
using morpholino-oligonucleotides (MOs) (Figure 6). A p53 MO
was injected to reduce off-target MO effects (Robu et al.,distribution of gH2AX (activated H2AX phosphorylated at Ser139) in non-UV irradi
gH2AX staining with a prominent nuclear foci pattern, characteristic of strong DD
(E and F) The effect of roscovitine on UV-triggered subcellular localization of CEP
and cytoplasmic marker 14.3.3 were analyzed by Western blot. Roscovitine decre
was most likely due to translocation of CEP164 into the nucleus upon roscovitine
increased phosphorylation of Chk1 at Ser317 (p-Chk1) (E), and roscovitine dec
cytoplasm and nucleus (E-F). Proteins 14.3.3 and Sam68 serve as controls for c
(G andH) Transient knockdown ofCep164 inhibits proliferation, which is rescued b
inducible mouse IMCD3 cells siRNA knockdown was performed. (G) IMCD3 c
nondepleted cells (control, blue line) or the nondepleted cells induced to express
depleted cells rescued the slow growth phenotype ofCep164 depletion (siRNA+do
expressed under doxycyclin control. Expression of this allele itself had a negative
even greater negative effect was seen when the endogenous Cep164 was deple
counts are plotted with standard deviations. Asterisks indicate significant differe2007). At 28 hr postfertilization (hpf) we observed the ciliopathy
phenotypes of ventral body axis curvature and cell death (Fig-
ure 6A–6C). Embryos showed increased expression of phos-
phorylated gH2AX (Figures 6D and 6E). At 48 hpf, cep164 mor-
phants displayed the typical ciliopathy phenotype of abnormal
heart looping (Figures 6F–6I). At 72 hpf, embryos developed
further NPHP-RC phenotypes, including pronephric tubule cysts
(Figures 6J and 6K), hydrocephalus, and retinal dysplasia
(Figures 6L–6M).
Depletion of CEP164 or ZNF423(Zfp423) Causes
Sensitivity to DNA Damaging Agents
To assess whether depletion of CEP164 causes sensitivity to
DNA damage, Cep164 expression was stably suppressed in the
mouse renal cell line IMCD3 (Figures 6P and 6Q).Cep164 knock-
down resulted in a dose-dependent increase of gH2AX intensity
levels in aFACSanalysis, signifying increased radiation sensitivity
to IR and perturbed DDR. Cellular sensitivity to IR was also seen
in cells depleted ofCEP164 using amulticolor competition assay
(MCA) (Smogorzewska et al., 2007) (Figures S7A and S7B).
To test whether ZNF423(Zfp423) affects DDR, we examined
P19 cells, which express high levels of endogenous Zfp423 (Fig-
ures 6R–6T). Replicate cultures infected with lentivirus express-
ing either scrambled control or Zfp423-targeted shRNA were
exposed to 0–10 Gy of X-irradiation and imaged for Zfp423
and nuclear gH2AX foci (Figure 6R). Quantification showed sig-
nificantly increased gH2AX intensities in Zfp423-depleted cells
at lower (0.5 and 1.0 Gy) exposures (Figure 6S), but the effect
was nonsignificant when corrected for the number of exposures.
To determine whether sensitivity to lower dose is reproducible,
we exposed 32 additional cultures at 1.0 Gy (Figure 6T). Normal-
ized gH2AX fluorescence in Zfp423 knockdown had both higher
mean (9.6 versus 4.7) and median (6.6 versus 5.2) values than
control (Figure 6T). These data replicate the radiation sensitivity
with high significance (p = 0.018, Mann-Whitney U test, 2 tails),
indicating that P19 cells require Zfp423 for quantitatively normal
DDR. These results are further confirmed by multicolor competi-
tion assays Figure S7C.
DISCUSSION
Disease Gene Identification Implicates NPHP-RC
Proteins in DDR
Many DDR signaling proteins localize to nuclear foci and
to centrosomes. In addition, dual localization of proteins atated cells suggesting partial DDR activation (C). UV radiation caused enhanced
R activation (D). (C and D) Error bars denote SEM.
164 and Chk1. CEP164 and Chk1 proteins, along with nuclear marker Sam68
ased the amount of CEP164 present in control and UV-irradiated cells (E). This
treatment as shown by subcellular fractionation (F). As expected, UV radiation
reased Chk1 protein expression and abrogated UV-induced p-Chk1 in both
ytoplasmic versus nuclear fraction, respectively. See also Figure S6.
y wild-type but notmutant CEP164. In clonally selected and doxycycline (Dox)-
ells depleted of murine Cep164 grew more slowly (siRNA, green line) than
human wild-type CEP164 (Dox, red line). Expression of WT Cep164 in siRNA-
x, purple line). (H) As in (G), exceptmutantCep164 cDNA (CEP164-Q525X) was
impact on cell growth (green line), suggesting a dominant negative effect. An
ted in cells expressing CEP164-Q525X (siRNA+dox, purple line). The average
nces by unpaired Student’s t test (p < 0.05).
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Figure 6. Knockdown of cep164 in Zebrafish Embryos Results in Ciliopathy Phenotypes, and Knockdown of Cep164 or Zfp423(Znf423)
Causes Sensitivity to DNA Damage
A morpholino-oligonucleotide (cep164 MO) targeting the exon 7 splice donor site of zebrafish cep164 was injected into fertilized eggs at the one to four-cells
stage together with p53 MO (0.2 mM) to minimize nonspecific MO effects.
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centrosomes and at nuclear foci has been demonstrated for
multiple known DDR proteins related to ataxia or CVH. Individ-
uals with mutations in the three NPHP-RC-causing genes that
we identify here, MRE11, ZNF423, and CEP164, share the
NPHP-RC phenotypes of CVH and ataxia. The first protein that
strongly linked DDR signaling to the ataxia phenotype was the
protein ATM (ataxia telangiectasia mutated) (Savitsky et al.,
1995). Interestingly, we identify here in individuals with NPHP-
RC, CVH and ataxia, mutations in proteins that colocalize to
nuclear foci with TIP60 and/or its interaction partner SC35.
These proteins are ZNF423, CEP164, and the previously identi-
fied NPHP-RC protein SDCCAG8/NPHP10 (Otto et al., 2010).
Our findings support the notion that many products of genes,
which if mutated cause NPHP-RC and/or ataxia, play a role in
DDR and are part of a dynamic protein complex.
A DDR-Based Pathogenic Hypothesis of Dysplasia and
Degeneration in NPHP-RC
We here generate evidence that NPHP-RC proteins exhibit dual
localization at centrosomes and in nuclear foci and that they play
a role in DDR. We also demonstrate the parallel occurrence of
DDR defects with an NPHP-RC phenotype upon cep164 knock-
down in zebrafish. We therefore propose that defects in DDR
may participate in the pathogenesis of NPHP-RC. Whereas
multiple signaling pathways have been implicated in the patho-
genesis of NPHP-RC (Hildebrandt et al., 2011), including nonca-
nonical (Simons et al., 2005) and canonical Wnt signaling (Yu
et al., 2009), Shh signaling (Huangfu et al., 2003), and mitotic
spindle orientation (Fischer et al., 2006), none of them con-
sistently explains the phenotypes observed. In particular, none
of these mechanisms provides a model for the dichotomy of
dysplasia phenotypes resulting from null-alleles of NPHP-RC
genes versus degenerative phenotypes resulting from hypomor-
phic alleles of the same NPHP-RC genes. Based on our findings(A–E) Whereas p53MO injection (n = 67) did not produce any phenotype (A), coin
body axis curvature in 48%of embryos (60/125) (B). 50%of embryos (62/125) sho
the head region (C). Embryos with severe cell death also showed increased exp
embryos with massive cell death did not survive beyond 48 hpf.
(F–I) At 48 hpf, surviving cep164morphants displayed the ciliopathy phenotype o
(F and G), cep164 MO caused inverted heart looping (H) or ambiguous heart loo
(J–M) At 72 hpf, cep164morphant embryos developed further ciliopathy phenoty
exhibited cystic dilation (K), asterisks) in 25% (7/28) of embryos, compared to p53
(asterisk), or retinal dysplasia (brackets) (M).
(N) At 0.2 mM, cep164 MO knockdown effectively altered mRNA processing as
aberrantly spliced mRNA product appeared in cep164 morphants (asterisks), an
affect cep164 mRNA processing.
(O) Quantification of g-H2AX levels in cep164MOmorphants.Whole-fish lysatesw
MO (p53 0.2 mM, cep164 0.2 mM). Injection of cep164-targeting MO causes upre
H2AX levels correlate with the phenotypic severity of the cep164 morphants (see
(P and Q) Cep164-deficient IMCD3 cells exhibit radiation sensitivity. In IMCD3 ce
shRNA knockdown to about 20%of control as judged by qPCR (P).Cep164 knock
assay, signifying increased radiation sensitivity to IR and perturbed DDR. See a
indicated by an asterisk. Error bars denote SEM.
(R–T) Zfp423(Znf423)-deficient P19 cells exhibit radiation sensitivity. P19 cells tran
Zfp423 and gH2AX immunofluorescence was quantified in matched replicate cu
dose-responsiveness of gH2AX and effective knockdown of Zfp423 expression.
and 1.0 Gy, signifying increased IR sensitivity and perturbed DDR (2 fields from
p< 0.05,Mann-WhitneyU test, 2 tails. (T) Histogram shows average gH2AX intens
p = 0.018, Mann-Whitney U test, 2 tails. See also Figure S7. Box plots delimit quwe here propose a pathogenic hypothesis for NPHP-RC that
implicates DDR signaling as a relevant disease mechanism.
Within this hypothesis, loss of function of NPHP-RC proteins
with a dual role in DDR and centrosomal signaling, would cause
disturbance of cell-cycle checkpoint control, which is particu-
larly detrimental for embryonic and adult progenitor cell survival.
This notion is in accordance with the orthologous mouse model
for ZNF423 loss of function, the Zfp423/mouse, in which CVH
with ataxia is caused by defective granule progenitor prolifera-
tion in the cerebellum (Alcaraz et al., 2006).
Within this pathogenic hypothesis for NPHP-RC, a DDR
signaling defect would lead to impairment of cell-cycle check-
point control, which in turn would cause lack of progenitor
cells. This hypothesis could lend a possible explanation to the
following persisting conundrum of NPHP-RC pathogenesis: in
certain NPHP genes (e.g., NPHP3, 6, or 8) null mutations cause
severe, congenital-onset phenotypes of dysplasia and malfor-
mation in kidney, eye, CVH, and liver, whereas hypomorphic
mutations in the same gene cause only late-onset degenerative
phenotypes such as renal tubular degeneration and fibrosis
(nephronophthisis), retinal degeneration (Senior-Loken syn-
drome), and liver fibrosis. However, the disease mechanisms
of neither the degenerative nor the dysplastic phenotypes are
understood. These findings suggest that null mutations act
during morphogenesis in embryonic development causing dys-
plasia and malformation, whereas hypomorphic mutations act
during the ‘‘chronic’’ processes of tissue maintenance and
repair, which are spread out over months or years of the life of
an organism. Because DDR signaling is in high demand under
conditions of high proliferation during development (morpho-
genesis), causing high ‘‘replication stress’’ to progenitor cells,
tissue dysplasia would be an expected pathogenic outcome.
Conversely, during tissue maintenance, low replication stress
would be expected, but persistent DDR impairment would allowjection of cep164MO at 28 hpf caused the mild ciliopathy phenotype of ventral
wed severe cell death throughout the body as judged by gray-appearing cells in
ression of phosphorylated gH2AX (D) compared to p53 MO control (E). Most
f laterality defects. Whereas p53MO did not cause any abnormal heart looping
ping (I). (A, atrium; L, left; V, ventricle).
pes. When compared to p53MO controls (J), pronephric tubules (arrow heads)
MO controls (J and L), 0% (0/67) of which showed kidney cysts, hydrocephalus
revealed by RT-PCR. The wild-type (WT) mRNA product is 339 bp. A shorter
d the normal mRNA product was significantly reduced. p53 MO alone did not
ere prepared frommorphants injected with control MO (p53 0.2mM) or cep164
gulation of g-H2AX in cep164morphant embryos signifying perturbed DDR. g-
A–C). Anti-a-tubulin antibody was used to show equal loading.
lls transduced with shRNA retrovirus, Cep164 expression was suppressed by
down resulted in a dose-dependent increase of gH2AX-positive cells in a FACS
lso Figure S7. In (Q) the level of significance of two-tailed t test (p < 0.001) is
sduced with shRNA lentivirus were exposed to the indicated level X-irradiation.
ltures for each virus 2 hr after irradiation. (R) Representative images illustrate
(S) gH2AX intensity normalized to DAPI+ nuclei is increased following IR at 0.5
each of 6 replicate cultures per condition). Asterisks, uncorrected pair-wise
ity per cell in 16 additional replicate cultures for each shRNA at 1.0Gy exposure.
artiles in (S).
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slow accumulation of DNA damage with a phenotype of tissue
degeneration.
At least two related findings support this model: (1) In a mouse
conditional knockout model of the cystic kidney disease
gene Pkhd1, knockout of the gene before 2 weeks of postnatal
life, up to which a high proliferation state prevailed, caused
(dysplastic) kidney cysts, whereas knockdown after 2 weeks
of postnatal life, when proliferation rate was shown to be
dramatically reduced, only caused occasional cysts, the number
of which increased when tissue injury was induced (Piontek
et al., 2007). This phenomenon could be explained by different
degrees of replication stress, and thereby DDR activation, under
different proliferation rates. (2) In Seckel syndrome (primordial
dwarfism), a progeria syndrome with CVH caused by mutation
of the centrosomal and DDR proteins ATR, CEP152, or pericen-
trin, the degree of cerebellar impairment is dependent on cell
proliferation state (Kalay et al., 2011; Murga et al., 2009; Rauch
et al., 2008).A DDR-Based Pathogenic Hypothesis Might Explain
Specific Organ Involvement in NPHP-RC
Regarding the question why organ degeneration occurs in
specific organs and at characteristic sites, it is tempting to spec-
ulate that the specific tissue regions or cell types affected in
NPHP-RC are more strongly exposed to genotoxins. In the
kidney, the distal convoluted tubule segment, around which
most fibrotic changes occur, is more strongly exposed to geno-
toxins such as hydroxyurea. Retinal degeneration could be
caused by postnatal accumulation of UV light-induced DNA
damage. Most strikingly, bile duct-surrounding cholangiocytes
in the liver are the one mammalian cell type that is most strongly
exposed to genotoxins that are generated by the liver for excre-
tion in bile.
In summary, a testable pathogenic hypothesis of NPHP-RC
that implicates DDR signaling, impaired cell-cycle checkpoint
control with lack of progenitor cells might potentially explain
some of the ill understood features of ciliopathies:
(1) It might provide a mechanism for the dual phenotypes of
degeneration/dysplasia seen in NPHP-RC in kidney, eye,
cerebellum and liver.
(2) It would implicate in the NPHP-RC pathogenesis, lack of
response to replication stress-sensing as a functional
basis for understanding the dualism of dysplasia that
occurs in high-proliferation states during development/
morphogenesis or repair versus degeneration, which oc-
curs during the low proliferation state of tissue mainte-
nance.
(3) It would characterize the degenerative phenotypes as
diseases of ‘‘organ-specific premature aging,’’ thereby
pointing in new directions for identification of small com-
pounds for therapy including cyclin inhibitors.
EXPERIMENTAL PROCEDURES
Research Subjects
We obtained human samples following informed consent from individuals with
NPHP-RC. Approval for human subjects research was obtained from the546 Cell 150, 533–548, August 3, 2012 ª2012 Elsevier Inc.University of Michigan Institutional Review Board and the other institutions
involved. The diagnosis of NPHP-RC was based on published clinical criteria
(Chaki et al., 2011).
Linkage Analysis
For genome-wide HM the GeneChip Human Mapping 250k StyI Array from
Affymetrix was used. Nonparametric LOD scores were calculated using a
modified version of the programs GENEHUNTER 2.1 (Kruglyak et al., 1996;
Strauch et al., 2000) and ALLEGRO (Gudbjartsson et al., 2000) in order to iden-
tify regions of homozygosity as described (Hildebrandt et al., 2009; Sayer et al.,
2006).
Bioinformatics
Genetic location is according to the February 2009 Human Genome Browser
data (http://www.genome.ucsc.eduH).
Immunoblotting and Immunoprecipitation
Immunoblotting and immunoprecipitation were performed as previously
described (Bryja et al., 2007). HEK293 cells were transfectedwith the indicated
constructs and lysed 48 hr later. Samples were analyzed using SDS-PAGE and
western blotting, or subjected to immunoprecipitation. The antibodies used for
immunoprecipitation are described in Extended Experimental Procedures.
cep164 Zebrafish Morpholino Oligo-Mediated Knockdown
MOs were obtained from Gene Tools, LLC (Philomath, OR). MOs (cep164 at
0.1 mM, standard control at 0.2 mM, and p53 MO at 0.2 mM) were injected
into zebrafish embryos at 1–4 cell stages. Embryos were fixed at 27 hpf with
4% PFA/PBS +1% DMSO overnight, permeablized with acetone at 20C
for 7 min, and stained with antibody against phosphorylated zebrafish
gH2AX (1:1,000, gift from Amatruda lab at UT Southwestern) or antibody
against cleaved Caspase-3 (1:200, BD Biosciences). Alex568-anti rabbit IgG
was used at 1:2,000 and 1:1,000 respectively. The IF procedure followed stan-
dard protocol. Morpholinos were: cep164 MO: 50-TATATGCTCTTCTCCATC
ACCTCAT; p53 MO: 50-GCGCCATTGCTTTGCAAGAATTG. For histological
analyses, embryos were fixed at 72 hpf with 4% PFA/PBS and embedded in
JB-4 resin (PolySciences) following themanufacturer’s protocol. Six millimeter
sections were obtained using a Leica R2265 microtome and stained with
hematoxylin-eosin following published procedures (Zhou et al., 2010).
Statistical Analysis
Student’s two-tailed nonpaired t tests and normal distribution two-tailed
z tests were carried out using pooled standard error and S.D. values to deter-
mine the statistical significance of different cohorts.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2012.06.028.
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